Skip to main content
. 2022 Dec 16;101(50):e32334. doi: 10.1097/MD.0000000000032334

Table 3.

VAS, Lequesne, and WOMAC scores of patients before and after treatment in the NBB and OAB groups.

Evaluation indicators NBB group (n = 59) OAB group (n = 64) T P value
Pretreatment VAS 4.32 ± 1.18 4.39 ± 1.09 −0.335 .739
Posttreatment VAS 2.27 ± 1.44 1.63 ± 0.85 3.069 .003
Pretreatment Lequesne 7.35 ± 2.47 7.50 ± 2.28 −0.356 .723
Posttreatment Lequesne 4.47 ± 2.76 3.09 ± 1.68 3.382 .001
Pretreatment WOMAC 40.58 ± 11.82 40.46 ± 11.11 −0.031 .957
Posttreatment WOMAC 29.80 ± 11.28 23.89 ± 7.57 3.433 .001
Pretreatment pain 8.64 ± 2.36 8.78 ± 2.19 −0.335 .739
Posttreatment pain 5.00 ± 2.74 3.27 ± 1.78 4.197 <.001
Pretreatment stiffness 3.53 ± 1.09 3.58 ± 1.04 −0.275 .784
Posttreatment stiffness 2.54 ± 1.15 2.17 ± 0.75 2.136 .035
Pretreatment function 28.41 ± 8.44 28.28 ± 7.96 0.085 .933
Posttreatment function 22.25 ± 8.17 18.45 ± 5.84 2.986 .003

NBB = normal or below normal body mass index, OAB = overweight and above body mass index, VAS = visual analog scale, WOMAC = Western Ontario and McMaster University Osteoarthritis.